US8183344B2
(en)
*
|
1996-04-24 |
2012-05-22 |
University Of Michigan |
Inactivation resistant factor VIII
|
US6479256B1
(en)
|
1998-03-04 |
2002-11-12 |
Icos Corporation |
Lectomedin materials and methods
|
KR20000046969A
(ko)
*
|
1998-12-31 |
2000-07-25 |
이선경 |
이종 유전자 유래의 유전자 발현 조절요소를 포함하는 강력한전사 활성을 가진 진핵세포 발현벡더
|
EP1325341A2
(de)
*
|
2000-10-12 |
2003-07-09 |
Icos Corporation |
Modulierung von ligandbindung/enzymatischer wirksamkeit von alpha- beta- proteinen
|
WO2002050264A2
(en)
*
|
2000-12-18 |
2002-06-27 |
Wyeth |
Promoters and recombinant expression constructs
|
PT1600510E
(pt)
*
|
2001-07-04 |
2007-06-25 |
Chromagenics Bv |
Sequências de adn com actividade anti-repressora.
|
ATE500331T1
(de)
*
|
2002-06-14 |
2011-03-15 |
Chromagenics Bv |
Verfahren zur gleichzeitigen herstellung von multiplen proteinen; vektoren und zellen, die hierfür verwendung finden
|
WO2003106674A2
(en)
*
|
2002-06-14 |
2003-12-24 |
Chromagenics B.V. |
Means and methods for regulating gene expression
|
CA2510179C
(en)
*
|
2002-12-18 |
2013-04-23 |
Chromagenics B.V. |
A method for improving protein production
|
DE60312039T2
(de)
*
|
2002-12-20 |
2007-11-08 |
Chromagenics B.V. |
Mittel und methoden zur produktion eines proteins durch chromatin-öffner, die chromatin zugänglicher für transkriptionsfaktoren machen können
|
AU2004275828B2
(en)
|
2003-09-23 |
2010-04-29 |
University Of North Carolina At Chapel Hill |
Methods and compositions for the correlation of single nucleotide polymorphisms in the vitamin K epoxide reductase gene and warfarin dosage
|
AU2005300503B2
(en)
*
|
2004-11-08 |
2010-12-16 |
Chromagenics B.V. |
Selection of host cells expressing protein at high levels
|
SI1809750T1
(sl)
|
2004-11-08 |
2012-08-31 |
Chromagenics Bv |
Izbira gostiteljskih celic, ki imajo visok nivo izraĹľanja proteina
|
US8039230B2
(en)
*
|
2004-11-08 |
2011-10-18 |
Chromagenics B.V. |
Selection of host cells expressing protein at high levels
|
US20060195935A1
(en)
*
|
2004-11-08 |
2006-08-31 |
Chromagenics B.V. |
Selection of host cells expressing protein at high levels
|
US8999667B2
(en)
*
|
2004-11-08 |
2015-04-07 |
Chromagenics B.V. |
Selection of host cells expressing protein at high levels
|
CA2590284A1
(en)
*
|
2004-12-08 |
2006-06-15 |
Icos Corporation |
Recombinant method for making multimeric proteins
|
JP2008532544A
(ja)
*
|
2005-03-15 |
2008-08-21 |
ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
活性ビタミンk依存性タンパク質を生産するための方法及び組成物
|
WO2007008848A2
(en)
*
|
2005-07-07 |
2007-01-18 |
Seattle Genetics, Inc. |
Monomethylvaline compounds having phenylalanine carboxy modifications at the c-terminus
|
EP3498289A1
(de)
|
2005-07-07 |
2019-06-19 |
Seattle Genetics, Inc. |
Monomethylvalinverbindungen mit phenylalaninseitenkettenmodifikationen am c-terminus
|
CN101292036B
(zh)
|
2005-10-21 |
2016-04-13 |
弗·哈夫曼-拉罗切有限公司 |
用于重组表达多肽的方法
|
CN101341252B
(zh)
|
2005-10-28 |
2011-08-17 |
弗·哈夫曼-拉罗切有限公司 |
啮齿动物细胞中的蛋白质表达
|
PL1969127T5
(pl)
*
|
2005-12-21 |
2018-02-28 |
Cnj Holdings, Inc |
Metoda wytwarzania biologicznie czynnych białek zależnych od witaminy K metodami rekombinacji
|
WO2007081336A1
(en)
*
|
2006-01-13 |
2007-07-19 |
Five Prime Therapeutics, Inc. |
Mammalian vectors for high-level expression of recombinant proteins
|
JP4870208B2
(ja)
|
2006-05-17 |
2012-02-08 |
エフ.ホフマン−ラ ロシュ アーゲー |
ポリペプチド産生細胞
|
US20090203077A1
(en)
*
|
2006-06-30 |
2009-08-13 |
The Regents Of The University Of Michigan |
Method of producing factor viii proteins by recombinant methods
|
EP2035572A4
(de)
*
|
2006-06-30 |
2010-01-06 |
Univ Michigan |
Verfahren zur herstellung von faktor-viii-proteinen durch rekombinationsverfahren
|
US20090143288A1
(en)
*
|
2007-03-13 |
2009-06-04 |
Roche Palo Alto Llc |
Peptide-complement conjugates
|
EP1975228A1
(de)
|
2007-03-28 |
2008-10-01 |
Fachhochschule Mannheim |
Polynukleotide für verstärkte Expression eines relevanten Polynukleotids
|
EP2517714A1
(de)
|
2007-04-26 |
2012-10-31 |
Inspiration Biopharmaceuticals, Inc. |
Rekombinante Vitamin-K-abhängige Proteine mit hohem Sialsäuregehalt und Verfahren zu ihrer Herstellung
|
RU2522481C2
(ru)
*
|
2007-06-29 |
2014-07-20 |
Ф.Хоффманн-Ля Рош Аг |
Мутант тяжелой цепи, приводящий к повышенной выработке иммуноглобулина
|
TR201816045T4
(tr)
|
2007-10-12 |
2018-11-21 |
Hoffmann La Roche |
Birden fazla nükleik asitten protein ekspresyonu.
|
EP3115469B1
(de)
|
2007-11-19 |
2020-04-29 |
Celera Corporation |
Lungenkrebsmarker und verwendungen davon
|
EP2280734B1
(de)
|
2008-04-24 |
2014-02-26 |
Cantab Biopharmaceuticals Patents Limited |
Faktor-ix-konjugate mit verlängerten halbwertszeiten
|
CA2975228C
(en)
|
2008-05-02 |
2020-07-21 |
Seattle Genetics, Inc. |
Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
|
NZ598275A
(en)
|
2009-08-06 |
2014-11-28 |
Cmc Icos Biolog Inc |
Methods for improving recombinant protein expression
|
US8822214B2
(en)
|
2009-09-15 |
2014-09-02 |
Medimmune Limited |
Cells for transient expression and uses thereof
|
JP5851410B2
(ja)
*
|
2009-10-30 |
2016-02-03 |
シーエヌジェイ ホールディングス、インク. |
組換えビタミンk依存性タンパク質の生成法
|
EP2339009A1
(de)
|
2009-12-22 |
2011-06-29 |
Sandoz Ag |
Kälteindusierbare Promotorsequenzen
|
HUE038788T2
(hu)
|
2010-03-31 |
2018-11-28 |
Boehringer Ingelheim Int |
Anti-CD40 antitestek
|
UA112062C2
(uk)
|
2010-10-04 |
2016-07-25 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
Cd33-зв'язувальний агент
|
BR112013011065B1
(pt)
|
2010-11-04 |
2022-03-15 |
Boehringer Ingelheim International Gmbh |
Anticorpo anti-il-23p19 humanizado ou seu fragmento de ligação ao antígeno, seu uso e composição farmacêutica
|
EP2655607A4
(de)
|
2010-12-21 |
2014-05-14 |
Univ North Carolina |
Verfahren und zusammensetzungen zur herstellung aktiver vitamin-k-abhängiger proteine
|
EP2753644A1
(de)
|
2011-09-09 |
2014-07-16 |
Universiteit Utrecht Holding B.V. |
Breit neutralisierende vhh gegen hiv-1
|
HUE037811T2
(hu)
|
2011-10-28 |
2018-09-28 |
Prothena Biosciences Ltd |
Alfa-szinukleint felismerõ humanizált antitestek
|
HUE047437T2
(hu)
|
2011-11-16 |
2020-04-28 |
Boehringer Ingelheim Int |
Anti-IL-36R antitestek
|
SG11201403445YA
(en)
|
2011-12-22 |
2014-07-30 |
Hoffmann La Roche |
Full length antibody display system for eukaryotic cells and its use
|
US9963511B2
(en)
|
2011-12-22 |
2018-05-08 |
Hoffmann-La Roche Inc. |
Expression vector organization, novel production cell generation methods and their use for the recombinant production of polypeptides
|
EP2794651B1
(de)
|
2011-12-22 |
2022-09-21 |
F. Hoffmann-La Roche AG |
Expressionsvektorelementkombinationen, neue verfahren zur produktionszellenerzeugung und deren verwendung bei der rekombinanten herstellung von polypeptiden
|
EP2807188B1
(de)
|
2012-01-27 |
2019-09-11 |
Prothena Biosciences Limited |
Alpha-synuclein erkennende humanisierte antikörper
|
CA2864092C
(en)
|
2012-02-10 |
2021-06-29 |
Seattle Genetics, Inc. |
Detection and treatment of cd30+ cancers
|
US20130230901A1
(en)
*
|
2012-02-14 |
2013-09-05 |
Portola Pharmaceuticals, Inc. |
Process for making recombinant antidote to factor xa inhibitor
|
CA2871985C
(en)
|
2012-05-03 |
2023-10-10 |
Boehringer Ingelheim International Gmbh |
Anti-il-23p19 antibodies
|
UA118441C2
(uk)
|
2012-10-08 |
2019-01-25 |
Протена Біосаєнсиз Лімітед |
Антитіло, що розпізнає альфа-синуклеїн
|
BR112015011462A2
(pt)
|
2012-11-20 |
2017-09-26 |
Univ North Carolina Chapel Hill |
processos e composições para proteínas fator ix modificadas
|
CA2904125C
(en)
|
2013-03-12 |
2022-06-07 |
Cmc Icos Biologics, Inc. |
Improved recombinant protein expression using a hybrid chef1 promoter
|
WO2014165271A2
(en)
|
2013-03-13 |
2014-10-09 |
Neotope Biosciences Limited |
Tau immunotherapy
|
US10513555B2
(en)
|
2013-07-04 |
2019-12-24 |
Prothena Biosciences Limited |
Antibody formulations and methods
|
RU2535871C1
(ru)
*
|
2013-07-10 |
2014-12-20 |
Общество с ограниченной ответственностью "Лаборатория медицинской биотехнологии" (ООО "ЛМБТ") |
Плазмида для экспрессии в клетке китайского хомячка, клетка китайского хомячка - продуцент белка с Gla-доменом и способ получения белка с Gla-доменом
|
US9951131B2
(en)
|
2013-07-12 |
2018-04-24 |
Prothena Biosciences Limited |
Antibodies that recognize IAPP
|
WO2015004632A1
(en)
|
2013-07-12 |
2015-01-15 |
Neotope Biosciences Limited |
Antibodies that recognize iapp
|
JP2017501848A
(ja)
|
2013-11-19 |
2017-01-19 |
プロセナ バイオサイエンシーズ リミテッド |
便秘症状からのレビー小体病の免疫療法のモニター
|
CN105873949A
(zh)
|
2014-01-31 |
2016-08-17 |
勃林格殷格翰国际有限公司 |
新的抗baff抗体
|
WO2015136471A1
(en)
|
2014-03-12 |
2015-09-17 |
Prothena Biosciences Limited |
Anti-laminin4 antibodies specific for lg1-3
|
TW201623331A
(zh)
|
2014-03-12 |
2016-07-01 |
普羅帝納生物科學公司 |
抗黑色素瘤細胞黏著分子(mcam)抗體類及使用彼等之相關方法
|
JP6728053B2
(ja)
|
2014-03-12 |
2020-07-22 |
プロセナ バイオサイエンシーズ リミテッド |
抗mcam抗体及び関連する使用方法
|
CA2938933A1
(en)
|
2014-03-12 |
2015-09-17 |
Prothena Biosciences Limited |
Anti-laminin4 antibodies specific for lg4-5
|
JP6744856B2
(ja)
|
2014-04-08 |
2020-08-19 |
プロセナ・バイオサイエンシズ・リミテッド |
α−シヌクレインを認識する抗体を含む血液脳関門シャトル
|
WO2016014775A1
(en)
|
2014-07-24 |
2016-01-28 |
Boehringer Ingelheim International Gmbh |
Biomarkers useful in the treatment of il-23a related diseases
|
TWI718122B
(zh)
|
2015-01-28 |
2021-02-11 |
愛爾蘭商普羅佘納生物科技有限公司 |
抗甲狀腺素運送蛋白抗體
|
TWI711631B
(zh)
|
2015-01-28 |
2020-12-01 |
愛爾蘭商普羅佘納生物科技有限公司 |
抗甲狀腺素運送蛋白抗體
|
TWI781507B
(zh)
|
2015-01-28 |
2022-10-21 |
愛爾蘭商普羅佘納生物科技有限公司 |
抗甲狀腺素運送蛋白抗體
|
JP6800863B2
(ja)
|
2015-02-06 |
2020-12-16 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
最適化されたヒト凝固第viii因子遺伝子発現カセットおよびその使用
|
KR20170135972A
(ko)
|
2015-04-14 |
2017-12-08 |
베링거 인겔하임 인터내셔날 게엠베하 |
질환을 치료하는 방법
|
KR20180023900A
(ko)
|
2015-05-12 |
2018-03-07 |
신티뮨, 인크. |
인간화된 친화성 성숙 항-FcRn 항체
|
WO2017046776A2
(en)
|
2015-09-16 |
2017-03-23 |
Prothena Biosciences Limited |
Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis
|
WO2017046774A2
(en)
|
2015-09-16 |
2017-03-23 |
Prothena Biosciences Limited |
Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis
|
TWI811716B
(zh)
|
2015-09-18 |
2023-08-11 |
德商百靈佳殷格翰國際股份有限公司 |
治療發炎性疾病之方法
|
WO2017070167A1
(en)
|
2015-10-20 |
2017-04-27 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for modified factor ix fusion proteins
|
WO2017149513A1
(en)
|
2016-03-03 |
2017-09-08 |
Prothena Biosciences Limited |
Anti-mcam antibodies and associated methods of use
|
WO2017153953A1
(en)
|
2016-03-09 |
2017-09-14 |
Prothena Biosciences Limited |
Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases
|
WO2017153955A1
(en)
|
2016-03-09 |
2017-09-14 |
Prothena Biosciences Limited |
Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases
|
WO2017180821A1
(en)
|
2016-04-15 |
2017-10-19 |
Boehringer Ingelheim International Gmbh |
Methods of treating inflammatory diseases
|
KR20190015704A
(ko)
|
2016-04-25 |
2019-02-14 |
신티뮨, 인크. |
인간화된 친화성 성숙 항-fcrn 항체
|
MY197413A
(en)
|
2016-05-02 |
2023-06-16 |
Prothena Biosciences Ltd |
Antibodies recognizing tau
|
JP7170316B2
(ja)
|
2016-05-02 |
2022-11-14 |
プロセナ バイオサイエンシーズ リミテッド |
タウ免疫療法
|
WO2017191560A1
(en)
|
2016-05-02 |
2017-11-09 |
Prothena Biosciences Limited |
Antibodies recognizing tau
|
WO2017208210A1
(en)
|
2016-06-03 |
2017-12-07 |
Prothena Biosciences Limited |
Anti-mcam antibodies and associated methods of use
|
JP7076711B2
(ja)
|
2016-07-02 |
2022-05-30 |
プロセナ バイオサイエンシーズ リミテッド |
抗トランスサイレチン抗体
|
JP7017013B2
(ja)
|
2016-07-02 |
2022-02-08 |
プロセナ バイオサイエンシーズ リミテッド |
抗トランスサイレチン抗体
|
EP3478715A2
(de)
|
2016-07-02 |
2019-05-08 |
Prothena Biosciences Limited |
Anti-transthyretin-antikörper
|
EP3472198B1
(de)
|
2016-09-29 |
2020-03-04 |
H. Hoffnabb-La Roche Ag |
Verbessertes verfahren zur auswahl von polypeptidproduzierenden zellen
|
WO2018071504A2
(en)
|
2016-10-14 |
2018-04-19 |
Boehringer Ingelheim International Gmbh |
Methods of treating diseases
|
EP3601350A1
(de)
|
2017-03-27 |
2020-02-05 |
Boehringer Ingelheim International GmbH |
Kombinationstherapie gegen il-36r-antikörper
|
WO2018204546A2
(en)
|
2017-05-02 |
2018-11-08 |
Prothena Biosciences Limited |
Antibodies recognizing tau
|
US10793634B2
(en)
|
2017-06-09 |
2020-10-06 |
Boehringer Ingelheim International Gmbh |
Anti-TrkB antibodies
|
CA3076313A1
(en)
|
2017-09-28 |
2019-04-04 |
Prothena Biosciences Limited |
Dosing regimes for treatment of synucleinopathies
|
AU2019206443A1
(en)
|
2018-01-10 |
2020-07-23 |
Cmc Icos Biologics, Inc. |
Bidirectional CHEFl vectors
|
US20210032316A1
(en)
|
2018-02-05 |
2021-02-04 |
Stichting Vu |
Inverse Agonistic Anti-US28 Antibodies
|
WO2019156566A1
(en)
|
2018-02-12 |
2019-08-15 |
Umc Utrecht Holding B.V. |
Bispecific molecules comprising gamma-delta tcr and t-cell or nk cell binding domain
|
WO2019226050A2
(en)
|
2018-05-24 |
2019-11-28 |
Wageningen Universiteit |
Novel viral anti-infective reagents
|
WO2019235923A1
(en)
|
2018-06-04 |
2019-12-12 |
Erasmus University Medical Center Rotterdam |
Role for low density lipoprotein receptor-related protein 10 in progressive brain diseases
|
KR20210027436A
(ko)
|
2018-06-29 |
2021-03-10 |
베링거 인겔하임 인터내셔날 게엠베하 |
자가면역 질환을 치료하는데 사용하기 위한 항-cd40 항체
|
CN110904127A
(zh)
|
2018-09-18 |
2020-03-24 |
瓦赫宁恩研究基金会 |
非洲猪瘟病毒疫苗
|
WO2020080941A1
(en)
|
2018-10-16 |
2020-04-23 |
Umc Utrecht Holding B.V. |
Anti- low-density lipoprotein receptor-related protein 5/6 antibodies
|
CA3117816A1
(en)
|
2018-11-26 |
2020-06-04 |
Forty Seven, Inc. |
Humanized antibodies against c-kit
|
WO2020130838A2
(en)
|
2018-12-21 |
2020-06-25 |
Qvq Holding B.V. |
Antibodies for preventing or treating candidiasis
|
BR112021016947A2
(pt)
|
2019-03-03 |
2021-11-03 |
Prothena Biosciences Ltd |
Anticorpos que reconhecem tau
|
US11730812B2
(en)
|
2019-03-08 |
2023-08-22 |
Boehringer Ingelheim International Gmbh |
Anti-IL-36R antibody formulations
|
WO2020204714A1
(en)
|
2019-04-02 |
2020-10-08 |
Immunetune B.V. |
Immune-stimulatory compositions and use thereof
|
BR112021019854A2
(pt)
|
2019-05-09 |
2022-02-15 |
Boehringer Ingelheim Int |
Anticorpos anti-sema3a e seus usos para o tratamento dos olhos ou de doenças oculares
|
TW202115112A
(zh)
|
2019-06-27 |
2021-04-16 |
德商百靈佳殷格翰國際股份有限公司 |
抗-angpt2抗體
|
TW202126685A
(zh)
|
2019-09-24 |
2021-07-16 |
德商百靈佳殷格翰國際股份有限公司 |
抗nrp1a抗體及其用於治療眼或眼部疾病之用途
|
JP2023528778A
(ja)
|
2020-05-26 |
2023-07-06 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
抗pd-1抗体
|
EP4288457A2
(de)
|
2021-02-05 |
2023-12-13 |
Boehringer Ingelheim International GmbH |
Anti-il1rap-antikörper
|
AR128065A1
(es)
|
2021-12-22 |
2024-03-20 |
Cdr Life Ag |
Anticuerpos anti-c3 y fragmentos de unión al antígeno de estos y sus usos para tratar enfermedades oftálmicas u oculares
|
CN114540352A
(zh)
*
|
2022-02-16 |
2022-05-27 |
艾瑞生命科学技术(常州)有限公司 |
一种多核苷酸、载体元件及表达载体和宿主细胞及应用
|
WO2024096735A1
(en)
|
2022-10-31 |
2024-05-10 |
Stichting Amsterdam UMC |
Single domain anti-cd169 antibodies
|
WO2024101989A1
(en)
|
2022-11-08 |
2024-05-16 |
Stichting Amsterdam UMC |
Activation inducible antigen receptors for adoptive immunotherapy
|